The roaring 2020s: a new decade of systemic therapy for renal cell carcinoma
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference61 articles.
1. Epidemiology of renal cell carcinoma;Capitanio;Eur Urol,2019
2. Epidemiology of renal cell carcinoma;Padala;World J Oncol,2020
3. Clinical stage migration and survival for renal cell carcinoma in the United States;Patel;Eur Urol Oncol,2019
4. Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States;Allard;Urol Oncol,2015
5. Clearing up clear cell: clarifying the immuno-oncology treatment landscape for metastatic clear cell RCC;Doppalapudi;Cancers (Basel),2021
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis;Scientific Reports;2024-08-30
2. Diagnostic accuracy and clinical impact of renal biopsy cytology;Diagnostic Cytopathology;2024-05-27
3. Belzutifan: a novel therapeutic for the management of von Hippel–Lindau disease and beyond;Future Oncology;2024-04-19
4. Single-cell analysis reveals ADGRL4+ renal tubule cells as a highly aggressive cell type in clear cell renal cell carcinoma;Scientific Reports;2024-01-29
5. Papillary Renal Cell Carcinoma: Demographics, Survival Analysis, Racial Disparities, and Genomic Landscape;Journal of Kidney Cancer and VHL;2023-12-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3